2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with Colonic Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Cheruku, RR; Dukh, M; Missert, JR; Pandey, RK; Patel, NJ; Spernyak, JA; Tabaczynski, W; White, WH; Zhang, S | 1 |
Cheruku, RR; James, NS; Missert, JR; Pandey, RK; Sunar, U | 1 |
Bellnier, DA; Gollnick, SO; Manderscheid-Kern, P; Owczarczak, B; Shams, M | 1 |
Brackett, CM; Gollnick, SO; Maier, PG; Owczarczak, B; Ramsey, K | 1 |
Ethirajan, M; Fan, W; Goswami, LN; Gupta, A; Hah, HJ; Kim, G; Kopelman, R; Lee, YE; Morgan, J; Pandey, RK; Pera, P; Wang, S | 1 |
Bellnier, DA; Greco, WR; Henderson, BW; Snyder, JW; Vaughan, L | 1 |
Busch, TM; Cheney, RT; Gollnick, SO; Henderson, BW; Kousis, PC; Morgan, J; Snyder, JW | 1 |
Baumann, H; Henderson, BW; Hutson, A; Rose-John, S; Tracy, E; Wang, Y; Wei, LH | 1 |
Bellnier, DA; Foster, TH; Henderson, BW; Mazurchuk, R; Seshadri, M; Spernyak, JA; Vaughan, LA | 1 |
9 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Colonic Neoplasms
Article | Year |
---|---|
The Structures of Gd(III) Chelates Conjugated at the Periphery of 3-(1'-Hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) Have a Significant Impact on the Imaging and Therapy of Cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chelating Agents; Chlorophyll; Colonic Neoplasms; Drug Screening Assays, Antitumor; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Optical Imaging; Photosensitizing Agents | 2020 |
Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
Topics: Animals; Carbocyanines; Chlorophyll; Colonic Neoplasms; Dose-Response Relationship, Radiation; Fluorescent Dyes; Glycoconjugates; Indoles; Infrared Rays; Mice; Mice, Inbred BALB C; Optical Imaging; Photobleaching; Photochemotherapy; Photosensitizing Agents; Propionates; Radiometry; Singlet Oxygen; Spectrometry, Fluorescence; Xenograft Model Antitumor Assays | 2018 |
Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.
Topics: Animals; Antineoplastic Agents; Chlorophyll; Colonic Neoplasms; Dihematoporphyrin Ether; Female; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Photochemotherapy; Photosensitizing Agents; Random Allocation; T-Lymphocytes; Transfection | 2015 |
IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Chlorophyll; Colonic Neoplasms; Dihematoporphyrin Ether; Drug Resistance, Neoplasm; Female; Interleukin-6; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neutrophils; Photochemotherapy; Photosensitizing Agents; T-Lymphocytes | 2011 |
Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
Topics: Acrylic Resins; Animals; Cell Line, Tumor; Chlorophyll; Colonic Neoplasms; Drug Carriers; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Photosensitizing Agents | 2011 |
Photodynamic therapy: a means to enhanced drug delivery to tumors.
Topics: Animals; Antibiotics, Antineoplastic; Capillary Permeability; Chlorophyll; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Delivery Systems; Drug Synergism; Female; Mice; Mice, Inbred BALB C; Photochemotherapy; Photosensitizing Agents | 2003 |
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Chemokine CCL4; Chlorophyll; Colonic Neoplasms; Endothelium; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; In Situ Nick-End Labeling; Interleukin-6; Macrophage Inflammatory Proteins; Mice; Mice, Inbred BALB C; Neutrophils; Nitroimidazoles; Oxygen; Photochemotherapy; Photosensitizing Agents | 2004 |
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
Topics: Animals; Blotting, Western; cdc25 Phosphatases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chlorophyll; Colonic Neoplasms; Culture Media, Conditioned; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; HeLa Cells; Humans; Interleukin-6; Macrophages; Mice; Mice, Inbred BALB C; Photochemotherapy; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor | 2007 |
Light delivery over extended time periods enhances the effectiveness of photodynamic therapy.
Topics: Animals; Cell Hypoxia; Chlorophyll; Colonic Neoplasms; Female; Light; Oxygen; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Inbred F344; Treatment Outcome | 2008 |